secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001104659-25-029887
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents restates 2023/2024 financials due to inventory and RSU errors
--------------------------------------------------------------------------

- Overstated inventory from clerical error; understated non-cash RSU expense due to using vesting-date fair value instead of grant-date.
- Non-reliance applies to audited FY2023 10-K and unaudited Q1-Q3 2023 and Q1-Q3 2024 quarterly reports.
- Restated financials will be included in the 2024 Annual Report on Form 10-K; prior reports should not be relied upon until then.
- Audit committee and management discussed the errors with the independent registered public accounting firm.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925029887/0001104659-25-029887-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465925029887/tm2510844d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-029887

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer